GSK ex-vaccines chief says group’s blockbuster flu jab is too expensive
Published
Emmanuel Hanon criticises former company’s vaccine after he raises $100mn for rival product
Full ArticlePublished
Emmanuel Hanon criticises former company’s vaccine after he raises $100mn for rival product
Full Article